Compare EVO & DC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | DC |
|---|---|---|
| Founded | 1993 | 2017 |
| Country | Germany | United States |
| Employees | 4766 | 41 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 895.8M | 783.8M |
| IPO Year | N/A | N/A |
| Metric | EVO | DC |
|---|---|---|
| Price | $2.76 | $5.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.00 | ★ $9.48 |
| AVG Volume (30 Days) | 106.1K | ★ 1.7M |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $2.62 |
| 52 Week High | $4.80 | $7.25 |
| Indicator | EVO | DC |
|---|---|---|
| Relative Strength Index (RSI) | 52.81 | 51.84 |
| Support Level | $2.32 | $5.37 |
| Resistance Level | $3.75 | $5.51 |
| Average True Range (ATR) | 0.08 | 0.28 |
| MACD | 0.07 | 0.10 |
| Stochastic Oscillator | 85.57 | 85.11 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine. Company project includes Richmond Hill Project.